112 related articles for article (PubMed ID: 30342672)
1. False positive result in non-invasive prenatal screening (NIPS).
Geok-Huey N; Kuo PL; Chang CH
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):772-773. PubMed ID: 30342672
[No Abstract] [Full Text] [Related]
2. Trisomy 13-confined placental mosaicism: is there an increased risk of gestational hypertensive disorders?
Dotters-Katz SK; Hardisty E; Campbell E; Vora N
Prenat Diagn; 2017 Sep; 37(9):938-939. PubMed ID: 28671725
[No Abstract] [Full Text] [Related]
3. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
4. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
5. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
[No Abstract] [Full Text] [Related]
6. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive prenatal testing.
Harraway J
Aust Fam Physician; 2017 Oct; 46(10):735-739. PubMed ID: 29036772
[TBL] [Abstract][Full Text] [Related]
8. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
Wald NJ
Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
[No Abstract] [Full Text] [Related]
9. Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods.
Conotte S; El Kenz H; De Marchin J; Jani JC
Am J Obstet Gynecol; 2022 Sep; 227(3):539-541. PubMed ID: 35577013
[No Abstract] [Full Text] [Related]
10. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
11. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 13 by robertsonian translocation rob (13;13)(q10;q10) +13: about one case.
Laudat A; Serero S; Seridi I; Burc-Struxiano L
Ann Biol Clin (Paris); 2017 Dec; 75(6):695-698. PubMed ID: 29043983
[TBL] [Abstract][Full Text] [Related]
13. Rate of no result in cell-free DNA testing and its influence on test performance metrics.
Grati FR; Kagan KO
Ultrasound Obstet Gynecol; 2017 Jul; 50(1):134-137. PubMed ID: 27731527
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.
García-Pérez L; Linertová R; Álvarez-de-la-Rosa M; Bayón JC; Imaz-Iglesia I; Ferrer-Rodríguez J; Serrano-Aguilar P
Eur J Health Econ; 2018 Sep; 19(7):979-991. PubMed ID: 29249015
[TBL] [Abstract][Full Text] [Related]
15. [Advance in clinical application of non-invasive prenatal screening using cell-free fetal DNA].
Hu J; Zhu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):924-927. PubMed ID: 29188632
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Projections in Neutrophils for Supporting the Diagnosis of Trisomy 13.
Kader Ş; Mutlu M; Aktürk Acar F; Aslan Y; Erduran E
Turk J Haematol; 2018 May; 35(2):144. PubMed ID: 28747288
[No Abstract] [Full Text] [Related]
17. Correlation between Z score, fetal fraction, and sequencing reads in non-invasive prenatal testing.
Balslev-Harder M; Richter SR; Kjaergaard S; Johansen P
Prenat Diagn; 2017 Sep; 37(9):943-945. PubMed ID: 28726258
[No Abstract] [Full Text] [Related]
18. Informed choice and decision making in women offered cell-free DNA prenatal genetic screening.
Lo TK; Chan KY; Kan AS; So PL; Kong CW; Mak SL; Lee CN
Prenat Diagn; 2017 Mar; 37(3):299-302. PubMed ID: 28004410
[No Abstract] [Full Text] [Related]
19. Genome-wide non-invasive prenatal screening for all cytogenetically visible imbalances.
Benn P; Grati FR
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):429-433. PubMed ID: 29363829
[No Abstract] [Full Text] [Related]
20. Re: Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false- negative cell-free DNA test result for trisomy 21.
Dabi Y; Costa JM; Benachi A
Ultrasound Obstet Gynecol; 2018 Feb; 51(2):278. PubMed ID: 29417678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
